Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc. > Vivo Cannabis Reduces Headcount 18%, To Sell Off Non-Core As
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(105)
•••
Comment by Schaffhausenon Oct 20, 2020 2:38pm
345 Views
Post# 31749122

RE:RE:RE:Vivo Cannabis Reduces Headcount 18%, To Sell Off Non-Core As

RE:RE:RE:Vivo Cannabis Reduces Headcount 18%, To Sell Off Non-Core As
I think we have officially hit rock bottom. The current valuation is below all peers with similar business performance. The actions taken by the management are difficult but will be rewarded by improved financials in the long run. Analysts should appreciate this effort to improve the bottom line as the top line is expected to continue to grow quickly. Value investors should begin to trickle in and grow with each subsequent quarterly report. Cheers, Schaff
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities